» Articles » PMID: 6850656

Phase II Study of Etoposide in the Treatment of Esophageal Carcinoma

Overview
Specialty Oncology
Date 1983 Apr 1
PMID 6850656
Citations 9
Authors
Affiliations
Soon will be listed here.
Citing Articles

Phase II trial of biweekly docetaxel, cisplatin, and 5-fluorouracil chemotherapy for advanced esophageal squamous cell carcinoma.

Tanaka Y, Yoshida K, Yamada A, Tanahashi T, Okumura N, Matsuhashi N Cancer Chemother Pharmacol. 2016; 77(6):1143-52.

PMID: 26896963 PMC: 4882360. DOI: 10.1007/s00280-016-2985-y.


Esophageal cancer chemotherapy: recent advances.

Ilson D Gastrointest Cancer Res. 2009; 2(2):85-92.

PMID: 19259300 PMC: 2630822.


Phase II trial of docetaxel chemotherapy in patients with incurable adenocarcinoma of the esophagus.

Heath E, Urba S, Marshall J, Piantadosi S, Forastiere A Invest New Drugs. 2002; 20(1):95-9.

PMID: 12003198 DOI: 10.1023/a:1014476602804.


13-Cis-retinoic acid and interferon alpha-2a in patients with advanced esophageal cancer: a phase II trial.

Slabber C, FALKSON G, Burger W, Schoeman L Invest New Drugs. 1996; 14(4):391-4.

PMID: 9157075 DOI: 10.1007/BF00180816.


Cisplatin and etoposide in oesophageal cancer: a phase II study. Rotterdam Oesophageal Tumour Study Group.

Kok T, van der Gaast A, Dees J, Eykenboom W, van Overhagen H, Stoter G Br J Cancer. 1996; 74(6):980-4.

PMID: 8826870 PMC: 2074745. DOI: 10.1038/bjc.1996.469.